Overview
A simulation-based technology for stochastic modeling, sensitivity analysis and design optimization, aimed at development of next-generation micro-fluidic devices for biomedical applications.
Infectious ailments affect more than 400M people worldwide annually, accounting for almost 30% of disability-
adjusted-life-years (DALYs, i.e. number of years lost due to ill-health, disability or early death), and for many of
these conditions, bringing affordable diagnosis andamp; effective therapeutic drugs to the point-of-need is key to
reducing morbidity and mortality. In this regard, micro-fluidics technology can be used to develop diagnostic
tools for pathogen detection that offer quick turnaround, clinically relevant detection limit, andamp; portability, and drug
discovery platforms for therapeutic drug synthesis that offer rapid screening, high throughput, andamp; reduced cost.
The rising popularity of such technology and its growing demand is driving innovation toward devices that need
to exhibit precision, durability, repeatability and reliability, and the proposed stochastic simulation-based
technology would support the development of such robust solutions, resulting in safer, more effective
biomedical devices that improve public health globally.
SOFTWORTHY